Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Signs on Three Rivers Provider Network for Payor Coverage

NEW YORK (GenomeWeb News) – CombiMatrix today said it has entered into a contractual agreement with preferred provider organization Three Rivers Provider Network for coverage of CombiMatrix's diagnostic laboratory services.

Three Rivers has more than 100 million members worldwide, including 15 million in the US, who now have access to CombiMatrix's molecular diagnostic tests and clinical support, specializing in prenatal, miscarriage, and pediatric healthcare. Three Rivers' network comprises 600,000 total providers, including more than 5,000 hospitals, and 70,000 ancillary facilities.

Today's announcement follows a contract the Irvine, Calif.-based company inked with Blue Shield of California in July to also cover its diagnostic laboratory services.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.